Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17


Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma.

Yin DT, Yu K, Lu RQ, Li X, Xu J, Lei M.

Medicine (Baltimore). 2016 Dec;95(52):e5794. doi: 10.1097/MD.0000000000005794. Review.


Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Wong KK, Gandhi A, Viglianti BL, Fig LM, Rubello D, Gross MD.

World J Radiol. 2016 Jun 28;8(6):635-55. doi: 10.4329/wjr.v8.i6.635.


Calculation of Blood Dose in Patients Treated With 131I Using MIRD, Imaging, and Blood Sampling Methods.

Piruzan E, Haghighatafshar M, Faghihi R, Entezarmahdi SM.

Medicine (Baltimore). 2016 Mar;95(11):e3154. doi: 10.1097/MD.0000000000003154.


Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

Calò G, Erdas E, Medas F, Gordini L, Longheu A, Pisano G, Nicolosi A.

G Chir. 2015 Nov-Dec;36(6):257-62.


Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region.

Hu J, Zhao N, Kong R, Wang D, Sun B, Wu L.

World J Surg Oncol. 2016 Jan 22;14(1):20. doi: 10.1186/s12957-016-0772-1.


Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.

Bal C, Ballal S, Soundararajan R, Chopra S, Garg A.

Cancer Med. 2015 Jul;4(7):1031-8. doi: 10.1002/cam4.443. Epub 2015 Mar 9.


Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?

Kiernan CM, Parikh AA, Parks LL, Solórzano CC.

J Am Coll Surg. 2015 Apr;220(4):617-25. doi: 10.1016/j.jamcollsurg.2014.12.014. Epub 2014 Dec 17.


Surgical decision making in the management of well-differentiated thyroid cancer.

Chernichenko N, Shaha AR.

Indian J Surg Oncol. 2012 Sep;3(3):161-5. doi: 10.1007/s13193-012-0148-0. Epub 2012 May 1.


Factors that influence radioactive iodine use for thyroid cancer.

Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR.

Thyroid. 2013 Feb;23(2):219-24. doi: 10.1089/thy.2012.0380.


The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ.

Cancer. 2013 Jan 15;119(2):259-65. doi: 10.1002/cncr.27721. Epub 2012 Jun 28.


Use of radioactive iodine for thyroid cancer.

Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ.

JAMA. 2011 Aug 17;306(7):721-8. doi: 10.1001/jama.2011.1139.


How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Sawka AM, Straus S, Gafni A, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Thabane L, Rodin G, Meiyappan S, David D, Goldstein DP.

Clin Endocrinol (Oxf). 2011 Apr;74(4):419-23. doi: 10.1111/j.1365-2265.2010.03966.x.


Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Sawka AM, Straus S, Brierley JD, Tsang RW, Rotstein L, Rodin G, Gafni A, Ezzat S, Thabane L, Thorpe KE, Goldstein DP.

Trials. 2010 Jul 26;11:81. doi: 10.1186/1745-6215-11-81.


Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence.

Naing S, Collins BJ, Schneider AB.

Thyroid. 2009 May;19(5):479-85. doi: 10.1089/thy.2008.0343.


The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Straus S, George SR, Abbey S, Rodin G, O'Brien MA, Gafni A, Thabane L, Goguen J, Naeem A, Magalhaes L.

PLoS One. 2009;4(1):e4191. doi: 10.1371/journal.pone.0004191. Epub 2009 Jan 14.


Invasive thyroid cancer: management of the trachea and esophagus.

Price DL, Wong RJ, Randolph GW.

Otolaryngol Clin North Am. 2008 Dec;41(6):1155-68, ix-x. doi: 10.1016/j.otc.2008.08.002. Review.


Role of surgery in treatment of advanced differentiated thyroid carcinomas.

Mattavelli F, Bombardieri E, Collini P, Costa L, Pizzi N, Fallahadar D, Pennacchioli E, Santamaria S, Cascinelli N.

Acta Otorhinolaryngol Ital. 2007 Apr;27(2):62-7.

Supplemental Content

Support Center